Bengt I. Eriksson - Concepedia

Author

Bengt I. Eriksson

Also Known As

Ann-Christin Arfwidsson, B ERIKSSON, B Eriksson, B I Eriksson, B. Eriksson, B. I. ERIKSSON, B. I. Eriksson, B.I Eriksson, B.I. ERIKSSON, B.I. Eriksson

282

Publications

24.1K

Citations

H-Index

114

Concepts

All Affiliations

Sahlgrenska University Hospital University of Gothenburg Thrombosis Research Institute Boehringer Ingelheim (Germany)Bayer (Germany)

About

Bengt I. Eriksson is an author at Sahlgrenska University Hospital specializing in medicine, orthopaedics, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	65	9.6K
2	Health Sciences	10	10	1.8K
3	Engineering	2	2	113
4	Public Health	1	1	113
5	Allergy	1	1	46

Bengt I. Eriksson

148

Publications

21.6K

Citations

H-Index

Page 1

	Year	Citations
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty Bengt I. Eriksson, Lars C. Borris, Richard J. Friedman, New England Journal of Medicine	2008	1.4K
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial Bengt I. Eriksson, Ola E. Dahl, Nadia Rosencher, The Lancet ThrombosisVenous DiseaseVenous ThrombosisVersus EnoxaparinHip Arthroplasty	2007	1.1K
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial Ajay K. Kakkar, Benjamin Brenner, Ola E. Dahl, The Lancet Total Hip ArthroplastyThrombosisVenous ThrombosisOrthopaedicsSurgery	2008	1.1K
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial Bengt I. Eriksson, O.E. Dahl, Nadia Rosencher, Journal of Thrombosis and Haemostasis Total Knee ReplacementThrombosisVenous DiseaseOral Dabigatran EtexilateVenous Thrombosis	2007	983
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery Kenneth A. Bauer, Bengt I. Eriksson, Michael R. Lassen, New England Journal of Medicine	2001	633
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery Bengt I. Eriksson, Kenneth A. Bauer, Michael R. Lassen, New England Journal of Medicine	2001	631
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial Alexander GG Turpie, Kenneth A. Bauer, Bengt I. Eriksson, The Lancet ThrombosisVenous ThrombosisVascular SurgeryOutcomes ResearchElective Hip-replacement Surgery	2002	533
The Achilles Tendon Total Rupture Score (ATRS) Katarina Nilsson‐Helander, Roland Thomeé, Karin Grävare Silbernagel, The American Journal of Sports Medicine	2006	456
Acute Achilles Tendon Rupture Katarina Nilsson‐Helander, Karin Grävare Silbernagel, Roland Thomeé, The American Journal of Sports Medicine	2010	416
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial Bengt I. Eriksson, O.E. Dahl, Harry R. Büller, Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisDabigatran EtexilateBlood PlateletMedicine	2004	412

Page 1